InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
07/03/24 2:42 PM
profile icon
Renee PremiumMember
04/22/24 10:41 AM
profile icon
$oldier Hard PremiumMember
03/25/24 10:31 PM
profile icon
$oldier Hard PremiumMember
03/18/24 11:45 AM
profile icon
glenn1919 PremiumMember
02/04/24 1:54 PM
profile icon
Sjam410 Free
10/13/23 9:01 AM
profile icon
Sjam410 Free
09/15/23 5:34 PM
profile icon
Sjam410 Free
09/15/23 2:53 PM
profile icon
Klinsmann PremiumMember
09/15/23 2:12 PM
profile icon
Sjam410 Free
09/15/23 1:57 PM
profile icon
Klinsmann PremiumMember
08/23/23 9:41 AM
profile icon
Klinsmann PremiumMember
08/22/23 4:24 PM
profile icon
Klinsmann PremiumMember
08/21/23 11:39 PM
profile icon
Klinsmann PremiumMember
08/19/23 1:09 PM
profile icon
Klinsmann PremiumMember
08/16/23 11:34 AM
Bullish
Bullish
profile icon
Klinsmann PremiumMember
07/28/23 9:52 AM
Bullish
Bullish
profile icon
budapestjs Free
07/27/23 5:22 PM
profile icon
Klinsmann PremiumMember
07/25/23 10:22 AM
Bullish
Bullish
profile icon
Triple nickle Free
07/18/23 10:10 AM
profile icon
Triple nickle Free
07/18/23 10:07 AM
profile icon
willlbone Free
06/22/23 9:55 AM
profile icon
$oldier Hard PremiumMember
06/22/23 9:40 AM
profile icon
$oldier Hard PremiumMember
05/11/23 2:38 PM
profile icon
budapestjs Free
03/13/23 10:06 AM
profile icon
$oldier Hard PremiumMember
01/25/23 3:10 PM
profile icon
$oldier Hard PremiumMember
01/06/23 3:32 PM
profile icon
$oldier Hard PremiumMember
11/11/22 2:02 PM
profile icon
$oldier Hard PremiumMember
06/24/22 11:49 AM
profile icon
budapestjs Free
06/23/22 10:23 PM
profile icon
$oldier Hard PremiumMember
06/23/22 11:14 AM
profile icon
NoobyDoo Free
04/27/22 8:55 PM
profile icon
$oldier Hard PremiumMember
04/20/22 11:01 AM
profile icon
$oldier Hard PremiumMember
12/30/21 11:19 AM
profile icon
NoobyDoo Free
11/19/21 12:14 PM
profile icon
$oldier Hard PremiumMember
11/11/21 10:04 PM
profile icon
NoobyDoo Free
11/11/21 5:25 PM
profile icon
$oldier Hard PremiumMember
11/09/21 9:25 AM
profile icon
NoobyDoo Free
11/08/21 7:31 PM
profile icon
$oldier Hard PremiumMember
10/27/21 12:01 PM
profile icon
$oldier Hard PremiumMember
09/24/21 10:02 AM

Pieris Pharmaceuticals Inc (PIRS) RSS Feed

Followers
49
Posters
107
Posts (Today)
0
Posts (Total)
526
Created
06/26/15
Type
Free
Moderators
Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris, founded in 2001, was funded by premier biotechnology-focused venture capital firms including OrbiMed Advisors as its lead investor as well as Forbion Capital, Gilde Healthcare Partners, Novo Nordisk Ventures, Global Life Science Ventures, BayTech Venture Capital, Bio-M, TCB, KfW and BayernKapital. Pieris has become a publicly traded company on December 18, 2014 (OTC:PIRS).
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post